Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Spin-Off Creates Enzyme to Prevent Celiac Disease

A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease. . . . → Read More: Spin-Off Creates Enzyme to Prevent Celiac Disease

Small-Business Grants Awarded for Neurological Diseases

A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders. . . . → Read More: Small-Business Grants Awarded for Neurological Diseases

Phone-Based Microscope Developed for Water Testing

An engineering lab at University of Houston in Texas designed an inexpensive lens that when placed over a smartphone’s camera, turns the phone into a microscope. . . . → Read More: Phone-Based Microscope Developed for Water Testing

Lilly, Institute Partner on Tuberculosis Drug Discovery

Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis. . . . → Read More: Lilly, Institute Partner on Tuberculosis Drug Discovery

Virtual Reality Game in Development for Vision Disorder

An engineering lab at New Jersey Institute of Technology is creating a virtual reality therapy game to treat children with binocular vision dysfunction. . . . → Read More: Virtual Reality Game in Development for Vision Disorder

Therapeutic Food-Triggered Gut Microbes in Development

A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins. . . . → Read More: Therapeutic Food-Triggered Gut Microbes in Development

Funds Provided for Developing RNA-Based Zika Vaccine

Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus. . . . → Read More: Funds Provided for Developing RNA-Based Zika Vaccine

Grant Funding Study of Gut Microbe Protection Drug

A biotechnology company developing drugs that protect the natural microbial balance in the gastrointestinal tract is receiving funds to learn how its drugs affect antibiotic resistance. . . . → Read More: Grant Funding Study of Gut Microbe Protection Drug

Fuel Cell Vehicles Reach Market, Seek Critical Mass

As the first hydrogen fuel cell vehicles go on sale, a group of companies and government agencies are seeking ways to encourage sales to help meet national goals for reducing greenhouse gases. . . . → Read More: Fuel Cell Vehicles Reach Market, Seek Critical Mass

Vaccine Stops Livestock Infections Without Antibiotics

A veterinary medical team at Kansas State University developed a vaccine that protects livestock against dangerous liver and skin infections without antibiotics. . . . → Read More: Vaccine Stops Livestock Infections Without Antibiotics